Skip to main content

and
  1. No Access

    Article

    Residual normal stem cells can be detected in newly diagnosed chronic myeloid leukemia patients by a new flow cytometric approach and predict for optimal response to imatinib

    Insensitivity of chronic myeloid leukemia (CML) hematopoietic stem cells to tyrosine kinase inhibitors (TKIs) prevents eradication of the disease and may be involved in clinical resistance. For improved treatm...

    J J W M Janssen, W Deenik, K G M Smolders, B J van Kuijk, W Pouwels, A Kelder in Leukemia (2012)